154 related articles for article (PubMed ID: 10866296)
1. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.
Abe N; Watanabe T; Masaki T; Mori T; Sugiyama M; Uchimura H; Fujioka Y; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 2000 Jun; 60(12):3117-22. PubMed ID: 10866296
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of high mobility group I(Y) protein expression in intraductal papillary mucinous tumors of the pancreas.
Abe N; Watanabe T; Izumisato Y; Masaki T; Mori T; Sugiyama M; Chiappetta G; Fusco A; Fujioka Y; Atomi Y
Pancreas; 2002 Aug; 25(2):198-204. PubMed ID: 12142746
[TBL] [Abstract][Full Text] [Related]
3. Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker.
Abe N; Watanabe T; Sugiyama M; Uchimura H; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 1999 Mar; 59(6):1169-74. PubMed ID: 10096541
[TBL] [Abstract][Full Text] [Related]
4. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
5. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases.
Chiappetta G; Manfioletti G; Pentimalli F; Abe N; Di Bonito M; Vento MT; Giuliano A; Fedele M; Viglietto G; Santoro M; Watanabe T; Giancotti V; Fusco A
Int J Cancer; 2001 Jan; 91(2):147-51. PubMed ID: 11146437
[TBL] [Abstract][Full Text] [Related]
6. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins.
Fedele M; Bandiera A; Chiappetta G; Battista S; Viglietto G; Manfioletti G; Casamassimi A; Santoro M; Giancotti V; Fusco A
Cancer Res; 1996 Apr; 56(8):1896-901. PubMed ID: 8620511
[TBL] [Abstract][Full Text] [Related]
7. Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.
Klotzbücher M; Wasserfall A; Fuhrmann U
Am J Pathol; 1999 Nov; 155(5):1535-42. PubMed ID: 10550310
[TBL] [Abstract][Full Text] [Related]
8. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.
Tallini G; Dal Cin P; Rhoden KJ; Chiapetta G; Manfioletti G; Giancotti V; Fusco A; Van den Berghe H; Sciot R
Am J Pathol; 1997 Jul; 151(1):37-43. PubMed ID: 9212729
[TBL] [Abstract][Full Text] [Related]
9. High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma.
Rho YS; Lim YC; Park IS; Kim JH; Ahn HY; Cho SJ; Shin HS
Acta Otolaryngol; 2007 Jan; 127(1):76-81. PubMed ID: 17364334
[TBL] [Abstract][Full Text] [Related]
10. Expression of the HMGI(Y) gene in human colorectal cancer.
Kim DH; Park YS; Park CJ; Son KC; Nam ES; Shin HS; Ryu JW; Kim DS; Park CK; Park YE
Int J Cancer; 1999 Aug; 84(4):376-80. PubMed ID: 10404089
[TBL] [Abstract][Full Text] [Related]
11. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the HMGI(Y) family of architectural transcription factors.
Reeves R
Environ Health Perspect; 2000 Oct; 108 Suppl 5():803-9. PubMed ID: 11035986
[TBL] [Abstract][Full Text] [Related]
13. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation.
Himes SR; Reeves R; Attema J; Nissen M; Li Y; Shannon MF
J Immunol; 2000 Mar; 164(6):3157-68. PubMed ID: 10706706
[TBL] [Abstract][Full Text] [Related]
14. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A
Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660
[TBL] [Abstract][Full Text] [Related]
15. HMGI(Y) gene expression as a potential marker of thyroid follicular carcinoma.
Czyz W; Balcerczak E; Jakubiak M; Pasieka Z; Kuzdak K; Mirowski M
Langenbecks Arch Surg; 2004 Jun; 389(3):193-7. PubMed ID: 15107999
[TBL] [Abstract][Full Text] [Related]
16. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.
Chiappetta G; Bandiera A; Berlingieri MT; Visconti R; Manfioletti G; Battista S; Martinez-Tello FJ; Santoro M; Giancotti V; Fusco A
Oncogene; 1995 Apr; 10(7):1307-14. PubMed ID: 7731681
[TBL] [Abstract][Full Text] [Related]
17. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes.
Tallini G; Vanni R; Manfioletti G; Kazmierczak B; Faa G; Pauwels P; Bullerdiek J; Giancotti V; Van Den Berghe H; Dal Cin P
Lab Invest; 2000 Mar; 80(3):359-69. PubMed ID: 10744071
[TBL] [Abstract][Full Text] [Related]
18. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.
Abe N; Watanabe T; Suzuki Y; Matsumoto N; Masaki T; Mori T; Sugiyama M; Chiappetta G; Fusco A; Atomi Y
Br J Cancer; 2003 Dec; 89(11):2104-9. PubMed ID: 14647145
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias.
Scala S; Portella G; Fedele M; Chiappetta G; Fusco A
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4256-61. PubMed ID: 10759549
[TBL] [Abstract][Full Text] [Related]
20. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.
Yantiss RK; Woda BA; Fanger GR; Kalos M; Whalen GF; Tada H; Andersen DK; Rock KL; Dresser K
Am J Surg Pathol; 2005 Feb; 29(2):188-95. PubMed ID: 15644775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
